Efficacy and Safety of the Prophylactic Use of Doxycycline +/- Vitamin K Cream

Study ID
NCT01345526

Study type
Interventional

Study phase
Phase 2

Study status
Completed

Trial Acronym

Trial Summary

The aim of this Phase 2, two-arm, randomized, double blind placebo controlled study is to evaluate the efficacy of combination therapy of doxycycline and Vitamin K1 compared to doxycycline plus placebo for the prevention of acne-like skin rash in mCRC patients receiving first line cetuximab treatment.

More informations

Trial Starting Date

Apr 30,2011

Requirements

Gender All
Minimum age 18 Years
Maximum age N/A

Enrollement Limit

124